UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

From an Idea to Reality: The Journey of Non-Invasive Cardiac Mapping

Yesterday was a milestone moment for Corify Care. We returned to where it all began—Hospital Gregorio Marañón—to officially present our non-invasive cardiac...

What if we could predict and prevent sudden cardiac death? Corify Care takes a bold step with the APOLO Project

Corify Care is thrilled to announce that it has been awarded a highly competitive grant from the National Research Agency following the...

We’re Hiring! Are you ready to shape the future of healthcare technology? Join Corify Care to revolutionize cardiovascular care and improve patient outcomes worldwide. 🌍

We are seeking a highly skilled and experienced Senior Software Developer to lead the development of innovative software solutions for our advanced...